Theranostics
The introduction of immune-modulating agents as a treatment option for bladder cancers has increased the survival rate in advanced and metastatic carcinomas. A large number of novel treatment modalities are under study, focussing on the tumor-specific aspects that can be targeted for achieving better treatment outcomes. ................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.